Morepen Laboratories Limited

NSEI:MOREPENLAB Stock Report

Market Cap: ₹43.3b

Morepen Laboratories Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Morepen Laboratories.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth17.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump

Aug 20
There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump

Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)

Aug 09
Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)

Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified

Jul 05
Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified

Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?

Jun 13
Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?

Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing

Apr 23
Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing

Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly

Nov 23
Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly

Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

Aug 10
Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Sep 21
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

Apr 05
Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?

Sep 14
Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?

Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

May 21
Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?

Mar 12
Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?

Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay

Feb 22
Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay

Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Feb 07
Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain

Jan 21
Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain

Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet

Jan 03
Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet

Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?

Dec 16
Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Morepen Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NSEI:MOREPENLAB - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202417,7481,313-436483N/A
6/30/202417,5711,177N/AN/AN/A
3/31/202417,019962-80734N/A
12/31/202316,422761N/AN/AN/A
9/30/202315,433531-15625N/A
6/30/202315,238477N/AN/AN/A
3/31/202314,220387-1,371-912N/A
12/31/202214,270428N/AN/AN/A
9/30/202214,765553-2,443-1,950N/A
6/30/202214,721768N/AN/AN/A
3/31/202215,5581,017-1,276-602N/A
12/31/202114,7431,161N/AN/AN/A
9/30/202113,8541,184-213520N/A
6/30/202113,2951,082N/AN/AN/A
3/31/202111,980971104508N/A
12/31/202011,136814N/AN/AN/A
9/30/202010,380684258389N/A
6/30/20209,183453N/AN/AN/A
3/31/20208,584336-60110N/A
12/31/20198,731331N/AN/AN/A
9/30/20198,530312-218-38N/A
6/30/20198,117340N/AN/AN/A
3/31/20197,71428855174N/A
12/31/20187,258252N/AN/AN/A
9/30/20186,672267N/AN/AN/A
6/30/20186,436308N/AN/AN/A
3/31/20186,101296N/A634N/A
3/31/20175,991236N/A407N/A
3/31/20164,861128N/A501N/A
3/31/20154,01421N/A507N/A
3/31/20143,670-28N/A335N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if MOREPENLAB's forecast earnings growth is above the savings rate (6.7%).

Earnings vs Market: Insufficient data to determine if MOREPENLAB's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if MOREPENLAB's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if MOREPENLAB's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if MOREPENLAB's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MOREPENLAB's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 13:58
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Morepen Laboratories Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vijay MadunalaFirstCall Research